Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

TGTX holding history

TG Therapeutics, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TGTX overviewAll 13F holders of TGTXFull Q2 2026 holdings

Shares (Q2 2026)
111,205
Value
$6.11M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TGTX by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026111,205$6.11M<0.1%+47,309+74.0%AddedHolders
Q1 202663,896$2.12M<0.1%+1,007+1.6%AddedHolders
Q4 202562,889$1.87M<0.1%−13,419−17.6%ReducedHolders
Q3 202576,308$2.76M<0.1%−4,445−5.5%ReducedHolders
Q2 202580,753$2.91M<0.1%−7,534−8.5%ReducedHolders
Q1 202588,287$3.48M<0.1%+29,427+50.0%AddedHolders
Q4 202458,860$1.77M<0.1%+3,028+5.4%AddedHolders
Q3 202455,832$1.31M<0.1%+8,993+19.2%AddedHolders
Q2 202446,839$833.3K<0.1%+12,076+34.7%AddedHolders
Q1 202434,763$528.7K<0.1%+5,958+20.7%AddedHolders
Q4 202328,805$492.0K<0.1%+3,181+12.4%AddedHolders
Q3 202325,624$214.2K<0.1%−1,474−5.4%ReducedHolders
Q2 202327,098$673.1K<0.1%+1,297+5.0%AddedHolders
Q1 202325,801$388.0K<0.1%+971+3.9%AddedHolders
Q4 202224,830$293.7K<0.1%−218−0.9%ReducedHolders
Q3 202225,048$148.0K<0.1%+167+0.7%AddedHolders
Q2 202224,881$106.0K<0.1%+24,881NewHolders
Q1 20220$00.0%−80,956−100.0%Sold outHolders
Q4 202180,956$1.54M<0.1%+54,716+208.5%AddedHolders
Q3 202126,240$873.0K<0.1%+6,110+30.4%AddedHolders
Q2 202120,130$781.0K<0.1%+8,829+78.1%AddedHolders
Q1 202111,301$545.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.